CD2 and neoplasm: The γ/δ+ lymphocytic tumor cells displayed a complete loss of CD2, partial downregulation of CD5, and showed no expression of CD4, CD30, CD56, TdT, or TCRαβ (clone 8A3/BetaF1) (Figure 2).